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Purpose: The aim of this work was twofold: (1) to examine whether, with standard automatic expo-
sure control (AEC) settings that maintain pixel values in the detector constant, lesion detectability in
clinical images decreases as a function of breast thickness and (2) to verify whether a new AEC setup
can increase lesion detectability at larger breast thicknesses.
Methods: Screening patient images, acquired on two identical digital mammography systems, were
collected over a period of 2 yr. Mammograms were acquired under standard AEC conditions (part
1) and subsequently with a new AEC setup (part 2), programmed to use the standard AEC settings
for compressed breast thicknesses ≤49 mm, while a relative dose increase was applied above this
thickness. The images were divided into four thickness groups: T1 ≤ 29 mm, T2= 30–49 mm,
T3= 50–69 mm, and T4 ≥ 70 mm, with each thickness group containing 130 randomly selected
craniocaudal lesion-free images. Two measures of density were obtained for every image: a BI-RADS
score and a map of volumetric breast density created with a software application (VolparaDensity,
Matakina, NZ). This information was used to select subsets of four images, containing one image
from each thickness group, matched to a (global) BI-RADS score and containing a region with the
same (local)  volumetric density value. One selected lesion (a microcalcification cluster or a
mass) was simulated into each of the four images. This process was repeated so that, for a given
thickness group, half the images contained a single lesion and half were lesion-free. The lesion
templates created and inserted in groups T3 and T4 for the first part of the study were then inserted
into the images of thickness groups T3 and T4 acquired with higher dose settings. Finally, all images
were visualized using the ViewDEX software and scored by four radiologists performing a free search
study. A statistical jackknife-alternative free-response receiver operating characteristic analysis was
applied.
Results: For part 1, the alternative free-response receiver operating characteristic curves for the four
readers were 0.80, 0.65, 0.55 and 0.56 in going from T1 to T4, indicating a decrease in detectability
with increasing breast thickness. P-values and the 95% confidence interval showed no significant
difference for the T3-T4 comparison (p= 0.78) while all the other differences were significant
(p< 0.05). Separate analysis of microcalcification clusters presented the same results while for mass
detection, the only significant difference came when comparing T1 to the other thickness groups.
Comparing the scores of part 1 and part 2, results for the T3 group acquired with the new AEC setup
and T3 group at standard AEC doses were significantly different (p= 0.0004), indicating improved
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detection. For this group a subanalysis for microcalcification detection gave the same results while
no significant difference was found for mass detection.
Conclusions: These data using clinical images confirm results found in simple QA tests for many
mammography systems that detectability falls as breast thickness increases. Results obtained with
the AEC setup for constant detectability above 49 mm showed an increase in lesion detection with
compressed breast thickness, bringing detectability of lesions to the same level. C 2016 American
Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4960630]
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1. INTRODUCTION
In many countries, full field digital mammography (FFDM)
has largely replaced screen-film mammography for the
purpose of screening program and diagnostic follow up. One
of the consequences of the large scale implementation of
mammography has been a thorough investigation of many
aspects of the mammography system setup together with the
optimization of system subcomponents. Several studies have
compared the detectability performance of FFDM against
screen-film mammography in clinical practice1–7 and found
FFDM to be equal or noninferior to screen-film mammog-
raphy. In terms of FFDM system optimization, investigators
have looked at beam quality, detector, system efficiency, and
operating dose level. Regarding beam quality, anode and filter
settings have been explored that maximized image quality
at the lowest dose.8–11 Other studies have investigated the
efficiency of mammographic systems in term of effective
detective quantum efficiency or effective noise equivalent
quanta.12,13 Potential for dose reduction has been explored
using simulated lesions.14,15
Notwithstanding the extensive investigation of FFDM
system setup in the literature, there has been little work
on lesion detectability for the range of different breast
thicknesses seen in clinical practice. Recent studies have
shown that theoretical detectability/visibility indexes such as
signal difference to noise ratio (SDNR) and threshold contrast-
detail (c-d) detectability decrease when test object thickness
increases,16–19 leading to a potential loss of lesion visibility
in clinical practice. This is a consequence of the automatic
exposure control (AEC) programming for many of the
mammographic systems on the market in which AEC devices
are designed or configured to maintain the signal, derived
from the image receptor, constant for all beam qualities,
irrespective of breast composition or thickness. This work
examines whether, for the standard AEC settings, simulated
lesion detectability decreases as a function of breast thickness
and whether new AEC settings that keep technical image
quality metrics constant as a function of thickness would bring
lesion detectability to the same level for all breast thicknesses.
This is achieved in a two-part study using simulated lesions
(both microcalcifications and masses), scored by experienced
radiologists in a free-response observer study. Images for the
first part of the study were acquired using the standard AEC
setting. New AEC settings were then programmed and used
to acquire the images used in the second part of the study. An
in-depth description and derivation of the new AEC has been
given in a previous study,16,17 along with detailed validation
using the CDMAM (Artinis BV, The Netherlands) c-d test
object as a function of poly(methyl methacrylate) (PMMA)
thickness. Hence, the aim of this study is to extend the previous
theoretical/phantom based work with a validation of the new
AEC setup using real mammograms.
2. MATERIAL AND METHODS
2.A. Selection of mammograms
Image acquisition was as follows. Patient images were
collected during two years of routine screening exami-
nations performed at the University Hospital of Leuven,
Belgium. During this period, both “for processing” and “for
presentation” images, acquired on two Siemens Mammomat
Inspiration systems (Siemens, Erlangen, Germany), were
collected and stored. The first year’s images were acquired
using the system standard automatic exposure control settings.
During the second year, the automatic exposure control was
set to use higher tube current-time product (mAs) values, and
hence radiation doses, to obtain technical detectability indexes
identical for breast equivalent thicknesses above 49 mm. The
methodology behind the modified AEC scheme is described in
the study of Salvagnini et al.16,17 which showed that the AEC
can be set up to keep detectability constant for test object
thicknesses above 40 mm, while maintaining mean glandular
doses (MGDs) below both the Acceptable and Achievable
levels of the European Guidelines.20
Following image acquisition, the simulation stage began.
The complete image database was analysed with the 
volumetric density software (VolparaSolutions, Wellington,
New Zealand)21,22 and a glandularity map was created for
each mammogram. Although  uses a proprietary
algorithm, the basic principle of operation is outlined in a
number of publications.21,23 An area of the breast that is
composed entirely of fatty tissue is required/found and the
pixel value (PV) within this region is taken as the reference
level from which the thickness of dense tissue overlying every
pixel in the image can be estimated. Additional information
required in making this estimate is the effective x-ray linear
attenuation coefficients for fatty and dense tissues for the
breast thickness and x-ray spectrum used.21,23 In part one,
520 craniocaudal mammograms were selected from patient
images acquired during the first year of data collection. The
inclusion criterion was the absence of lesions, apart from
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calcified vessels and macrocalcifications, considered to hold
no relevance for the subsequent reading studies. During the
selection of the images, the BI-RADS density score was
assigned to each mammogram by an expert radiologist with
more than 20 yr of experience in breast cancer imaging.
Four groups, each with 130 images, were created according
to compressed breast thickness: group T1 ≤ 29 mm, group
T2= from 30 to 49 mm, group T3= from 50 to 69 mm, group
T4 ≥ 70 mm. The images were used as normal backgrounds
for the insertion of simulated masses and microcalcification
clusters. In the second part of the study, 260 craniocaudal
mammograms were selected from patient images acquired
during the second year of data collection with the modified
AEC setting. Again, 130 mammograms were selected for
inclusion in thickness groups T3 and T4, following the same
criteria as in part 1. The BI-RADS score was also assigned
by the same expert radiologist. For the second part of the
study, only thickness groups T3 and T4 were investigated;
the reason for this is outlined in the preceding study that
described the theory behind the new AEC settings.16 In that
work, an AEC design was discussed that held detectability
of targets at some constant level (i.e., the Achievable image
quality level in the EC guidelines) as breast thickness changed.
While this setting would actually reduce the dose to thinner
breasts (i.e., breasts in thickness groups T1 and T2), it is
likely that the dose reduction would be accompanied by a
reduction in image quality and hence the decision was taken
not to apply the new AEC setup at small breast thickness.
This led to the idea of a composite AEC where the original
AEC function (that held PV constant) was left in place for
groups T1 and T2 and the new AEC control, that increased
detector PV, was applied for thicker breasts (groups T3 and
T3). The main idea was therefore to improve image quality
and lesion detectability at large breast thicknesses and to try
and bring this closer to that for small breast thicknesses, while
maintaining breast doses below the European Guideline limits
for digital mammography. Hence, for the second part of the
study, the setup of the AEC was a combination of the standard
AEC mode (patient breast thickness ≤ 49 mm) and the new
AEC mode (patient breast thickness ≥ 50 mm). Average MGD
for the two parts was calculated from the organ dose values
held in the DICOM headers using tag {0040,0316} “Organ
Dose”; accuracy of the stored organ dose value for these two
systems is checked during biannual QC checks and was within
5% of the calibrated value.
2.B. Simulated lesions and simulation tool
A database of 70 lesions, of which 35 were simulated
microcalcification clusters and 35 were simulated masses,
was used in this study. The creation of the lesion models
used in this study is described in the work of Shaheen
et al.,24,25 along with their validation in terms of realism
in FFDM and in breast tomosynthesis. Both spiculated
and nonspiculated masses were used.24 Similar models of
simulated microcalcification clusters had been validated and
used in previous observer studies to compare image processing
algorithms.26,27 Simulated lesions rather than real pathological
cases were chosen for this study as this allowed control over
the number of lesions in the different thickness groups along
with the contrast, position, and size of the lesions, without
having to acquire thousands of screening mammograms
especially for the quite sparsely populated subgroups like very
thick or very thin breasts. The possibility of controlling and
fixing these parameters is fundamental to the investigation of
the influence of breast thickness on lesion detectability.
The creation of abnormal cases was performed by inserting
simulated lesions in normal mammograms using a simulation
tool developed to simulate 3D objects into 2D mammograms
and validated previously by Shaheen et al., a detailed descrip-
tion of which can be found elsewhere.24,28 The simulation
accounts for the geometry of the mammographic system
and for system specific characteristics such as presampling
modulation transfer function (MTF) and scatter fraction (SF).
The scatter values used in the simulation tool for this study
were taken from the work of Salvagnini et al.29 The lesion tem-
plate was also adjusted for clinical parameters specific to the
mammogram of interest, such as compressed breast thickness,
acquisition spectrum, background glandularity percentage and
beam quality. Moreover, the composition and diameter of the
simulated lesion can be specified. In this work the materials
selected for the simulation of masses and microcalcifications
were 100% glandular tissue and calcium oxalate, respectively.
The minimum and the maximum diameters of the simulated
microcalcification clusters were 1 and 6.2 mm. The diameter
of the largest microcalcification present in the clusters
ranged from 0.31 to 1.46 mm. The average diameter of the
largest microcalcification of the study was 0.65 mm. For the
simulated masses, the diameters ranged from 4.6 to 16.8 mm.
These diameters were calculated from the template of the
lesion before insertion in the mammogram. Lesion templates
were inserted into for processing DICOM images and then
processed.
2.C. Creation of abnormal cases
Each thickness group contained 130 images of which
60 were used as normal images and 70 were used to
create abnormal cases; in half of these images simulated
microcalcification cluster (35 different models) were inserted;
in the other half, simulated masses (35 different models) were
inserted. Lesions were always simulated into for processing
images.
To perform the insertion of a lesion, four patient images
were selected at the same time, namely one image for each
thickness group. Two specific criteria were required for the
selection of these images: (1) the same BI-RADS density
score and (2) an area of the image with the same glandularity
percentage (g%). The glandularity percentage values were
taken from  glandularity maps. An example of four
such mammograms, with BI-RADS density score equal to 2,
is shown in Fig. 1.
The selection criteria for the images play an important role
in controlling the influence of mammographic background
structure on lesion detection and isolating the effect of
thickness. Lesion templates were created to be “subtle,” “not
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F. 1. Four mammograms of four different thickness groups, presenting the same BI-RADS score. These mammograms were selected for the insertion of the
same template.
visible” or “obvious” in mammograms having compressed
breast thickness between 40 and 59 mm, i.e., group T2.
This thickness range was selected because the average breast
thickness of the female population falls in this range. In
particular for the subtle cases, 17 masses and 17 microcal-
cification clusters were created in patients with compressed
breast thickness between 40 and 49 mm while 7 masses and
8 microcalcification clusters were created in mammograms
with thickness ranging between 50 and 59 mm. Creation of
a lesion template entailed adjusting the 3D model in size and
thickness until it could be considered to be subtle, obvious,
or not visible after processing the image. Appearance and
positions of the templates were verified by an experienced
radiologist who did not take part in the reading study. After
the creation of a template for one specific thickness group, the
same model was inserted with identical attenuation coefficient
and adjusted scatter fraction in the other 3 thickness groups
in images presenting the same BI-RADS score and local
percentage glandularity score. Examples of zoomed areas of
21% local glandularity value before and after the insertion of
a mass are shown in Fig. 2. These image segments were taken
from the mammograms shown in Fig. 1.
In part 2 of the study, the same lesion templates created
and used in part 1 were then inserted into the new set of
mammograms acquired with the new AEC setup. As explained
in Sec. 2.A, the new AEC settings only affected breasts
with thicknesses falling into groups T3 and T4. Images in
which a lesion was simulated were matched in terms of
the BI-RADS density score, local glandularity score, and
compressed breast thickness of these mammograms with the
mammograms already used in part 1. Keeping these three
parameters equal between the selected mammograms allowed
the influence of dose (and hence the new AEC setting) on
lesion detectability to be isolated while minimizing the effects
F. 2. Zoom of the areas selected for insertion from the mammograms in Fig. 1. The areas had a g% value equal to 21%. Areas before lesion insertion are
shown in the upper row and the same areas after lesion insertion are represented in the lower row.
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of background glandularity and breast thickness. For both
parts of the study, lesions were simulated in the whole breast
area (x,y) but avoiding regions of the pectoral muscle, the
skin edge, and the nipple. In terms of depth within the breast
(z position), lesions were always placed half way between
the compression paddle and the detector cover. The local
glandularity percentage values of the backgrounds ranged
from 7% to 28% for masses and from 7% to 31% for
microcalcification clusters. Each abnormal case contained
only one simulated lesion. All images, normal and abnormal,
were processed with the Siemens standard image processing
algorithm for 2D digital mammography, OpView2 (Siemens,
Erlangen, Germany).
2.D. Observer performance study
Four radiologists participated in the study. They had
between 1 and 20 yr of experience in reading mammograms
and in particular between 1 and 10 yr of experience with digital
mammography images; they read at least 20 000 mammo-
grams/yr. The observer performance study consisted in a free-
response paradigm.30,31 All observers read all images of both
study parts and were told that each case could contain zero,
one or more lesions. Readers were asked to mark the center
of any region where they suspected the presence of a lesion,
be it a mass or a microcalcification cluster. Image display
and flow was controlled using ViewDEX software,32,33 which
allows the user to pan, zoom, window/level and put marks
in an image. After a mark has been placed, a small cross
remains on the image. Marks can be hidden or deleted during
the scoring of the image; it is not possible to change the score
of a previous image. Following the mark up of a lesion, the
observer was presented with three questions:
• What is the confidence of the presence of the lesion?
This question was answered on a 5-point scale: (1) Very
unlikely to be a lesion. (2) Probably not a lesion. (3)
Possibly a lesion. (4) Probably a lesion. (5) Definitely a
lesion.
• What is the lesion type? Observers could choose between
mass or microcalcification cluster.
• What is the likelihood that this lesion is malignant?
This question was also answered on a 5-point scale:
(1) Definitely benign. (2) Probably benign. (3) Possibly
malignant. (4) Probably malignant. (5) Definitely malig-
nant. (Note that results of this question are not used for
in this study, and therefore not reported.)
The software recorded each score of an observer with the
relative coordinates, the answers to the questions, and image
reading time.
The first part of the study consisted of 13 sets of images
each containing 40 images; the second part of the study
consisted of 7 image sets, 6 sets of 40 images, and one of
20 images. An extra section of 24 images was for training
before the actual study commenced. Average reading time per
session was 35 min. All images were displayed on 5 megapixel
medical grade Barco monitors (Barco, Kortrijk, Belgium)
which were calibrated to the DICOM grayscale standard
display function GSDF. Ambient light was <10 Cdm−2 and
the monitors were positioned such that screen reflections were
eliminated, a situation that represents the standard clinical
conditions for mammography reading.
2.E. Statistical analysis
A lesion can be marked or not marked, leading to the
standard range of false positive (FP), true positive (TP), false
negative (FN), and true negative (TN) results. To determine
the category of each mark, an acceptance radius of 25 pixels
(2.125 mm) was defined around the lesion center to the mark.
If the mark was placed within this radius, the result was
considered as a TP.34 This classification of the marks together
with their rating was used as input file for the jackknife-
alternative free-response receiver operating characteristic
() software (, version 4.2.1, Chakraborty) avail-
able from http://www.devchakraborty.com. This software was
used to perform a  analysis.30 In this analysis, the
figure of merit (FoM) is the probability that a lesion rating
exceeds the highest rated nonlesion rating on normal images
and is calculated as the trapezoidal area under the alternative
free-response receiver operating characteristics (AFROC).
The software performs significance testing using the 
technique described by Dorfman, Berbaum, and Metz.35,36
The software produced different results when analyzing the
cases and the readers as random or fixed. In this study, only
results for random cases and random readers will be presented
because these results can be applied to the whole population
of readers and cases. The overall results for the significance
of the statistical analyses are presented as F-statistics and
degrees of freedom for both parts of the study. The statistical
significance for comparison of the modalities, intended as
thickness groups for part 1 of the study and as doses for part
2 of the study, is presented as the AFROC area, p-values, and
the 95% confidence interval.
3. RESULTS
3.A. Mean glandular dose and exposure time
Before discussing the observer results in detail we first
give some breast dose and exposure time information for the
standard and modified AEC modes. For the part 1 dataset,
average MGDs for thickness groups T1 (≤29 mm), T2
(30–49 mm), T3 (50–69 mm), and T4 (≥70 mm) were 0.90,
1.03, 1.20, and 1.57 mGy, respectively. Following the dose
increase for part 2, the average MGD was 1.94 mGy for
group T3 and 2.67 mGy for group T4, indicating an increase
of dose of 60% and 70% for the two investigated thickness
groups. Despite the higher MGDs given to patients in part
2, doses remained below the Achievable dose limit indicated
in the European guidelines.20 The mean glandular doses of
the patients used in parts 1 and 2 of the study are presented in
Fig. 3 for the different thickness groups. Because patients were
chosen for their thickness only, the distribution of BI-RADS
scores is random and includes all categories.
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F. 3. Patient MGD for parts 1 and 2 of the study, divided by thickness
group. The Acceptable and the Achievable dose limits prescribed by the
European guidelines are also indicated.
The patient doses for part 2 of the study for T3 and
T4 thickness groups shown in Fig. 3 have a larger spread
compared to the same thickness groups for the standard AEC
mode. This is probably due to the modified AEC aiming for
a higher target pixel value for the thicker breasts. This target
PV for the modified AEC mode is 60% and 70% higher for
T3 and T4 respectively, resulting in a larger range of mAs
values that can be selected in reaching the target. The AEC
selects a certain mAs value based on a preshot exposure that
searches the most dense area of the breast. Local breast density
variation across the breast will produce a larger variation of
mAs values and hence an increased range of MGD values for
the women.
Accompanying the dose increase is a lengthening of
exposure time which can increase the probability of motion
blurring and ultimately lead to blurring of the imaged anatomy.
In this study the average exposure times in part 1 for the
different thickness groups were 0.56, 0.59, 0.71, and 0.98 s, for
groups T1 to T4, respectively. For part 2 the average exposure
times were 1.11 and 1.63 s for T3 and T4 respectively,
an increase of 56% and 66% over part 1. This increase of
exposure time follows that of the MGD increase, as expected if
tube current is held constant. The exposure time values found
for part 2 were compared to those in the work of Berns et al.37
for screen-film and digital mammography, where exposure
times for 4.5 and 6 cm of breast equivalent material were
respectively 1.05 and 1.61 s, for screen-film mammography
T II. Shown is the overall significance of the test for the different parts
of the study. The numerator and the denominator of the degrees of freedom,
the F-statistics, and the p-value are presented. A p-value smaller than 0.05
means that at least one pair of modalities compared in the test is significantly
different. The symbol · indicates no significant difference.
Study
Degree of freedom (numerator,
denominator) F-statistics p-value
Part 1 (3, 113.99) 16.39 <0.0001
Part 2 (50–69 mm) (1, 219.17) 12.79 0.0004
Part 2 (>70 mm) (1, 6.55) 2.29 0.1305·
and 0.70 and 0.79 s for digital mammography. Hence average
exposure times for study for part 2 were similar to those
for screen-film mammography, with average breast thickness
equal to 59.6 and 73.3 mm, for groups T3 and T4, respectively.
3.B. Observer detection results
Table I presents the number of correct lesion marks
(TP) for the different thickness groups. Each cell shows the
number of the lesions marked correctly together with the total
number of lesions present in the specific thickness groups and
the percentage of correct lesion marks. Columns 2–4 show
the results of part 1 of the study in which the influence
of compressed breast thickness on lesion detectability is
investigated for the system standard AEC setup. The results
of part 2 of the study, using the modified dose setting, are
shown in columns 5–7. Results for both parts are shown
for all lesions, and for microcalcification clusters and masses
separately.
Table II presents the overall results of the  analysis
for the different parts of the study. In this table the degrees
of freedom and the F-statistic together with the p-value are
shown. A p-value inferior to 0.05 means that at least one pair
of modalities compared in the test is significantly different. For
the first part of the study, the overall p-value was statistically
significant (<0.0001 and F = 16.39). The analysis of the
second part of the study, which compared different dose levels
for the same thickness group, was performed considering each
thickness range separately. The p-values were 0.0004 for T3
(50–69 mm) and 0.1305 for T4 (>70 mm).
Figure 4 shows an example of a simulated mass inserted
in the four T-groups and acquired with standard AEC mode
T I. Shown is the number of the true positive marks for all readers for each thickness group for the total of the lesions and for microcalcification clusters
and masses separated. The total number of lesions, microcalcification clusters, and masses is also shown together with the percentage ratio. Results are shown
for both parts of the study.
Part 1 (standard AEC setting) Part 2 (new AEC setting)
Correct lesions
marked/total
lesions
Correct microcalcification
clusters marked/total
microcalcification clusters
Correct masses
marked/total masses
Correct lesions
marked/total lesions
Correct microcalcification
clusters marked/total
microcalcification clusters
Correct masses
marked/total masses
T1 (≤29 mm) 197/280 (70%) 86/140 (61%) 111/140 (79%)
T2 (30–49 mm) 144/280 (50%) 81/140 (58%) 63/140 (45%)
T3 (50–69 mm) 94/280 (34%) 45/140 (32%) 49/140 (35%) 130/280 (46%) 69/140 (49%) 61/140 (44%)
T4 (≥70 mm) 104/280 (37%) 37/140 (26%) 67/140 (48%) 121/280 (43%) 58/140 (41%) 63/140 (45%)
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F. 4. A mass template inserted in (left column) the four T-groups, for standard AEC dose settings and (right column) T3 and T4 for the new AEC dose settings.
All images were BI-RADS category 2 and the template was inserted in an area of  glandularity value equal to 10%.
(left column) and acquired with the new AEC mode for T3
and T4 (right column). In this example, the readers did not
detect the masses present in the images of T3 and T4 acquired
with standard AEC dose while they successfully detected the
masses of the same groups acquired with new AEC dose. A
similar example for a microcalcification cluster is shown in
Fig. 5.
3.C. Part 1—Lesion detectability as a function
of breast thickness
3.C.1. Analysis for all lesions, for masses
and for microcalcification clusters
The results of the FoM for part 1 of the study considering all
lesions are shown in Fig. 6(a) and values are listed in Table III.
The AFROC curves are plotted as lesion localization fraction
(LLF) as a function of false positive fraction (FPF). The area
under the AFROC curve decreases from 0.802 to 0.553 with
increasing thickness from T1 to T3 while the AFROC area for
T4 (0.565) was found to be almost equal to T3.
The results of the p-values and the 95% confidence interval
(CI) for the paired comparison of the different thickness
groups are presented in Table IV. A p-value smaller than
0.05 and a CI that does not include zero mean a significant
difference between the two thickness groups being compared.
All the p-values were smaller than 0.05 and the 95% CI did
not include zero except for the comparison of T3 and T4
where the p-value was equal to 0.7757 and the 95% CI was
(−0.0909,0.0680). This indicates that these two groups are
considered not significantly different, which was expected
given the similar values found for the AFROC areas of the
T3 and T4 groups.
F. 5. The figure shows a microcalcification cluster template inserted in (right column) the four T-groups, for standard AEC dose settings and (left column) T3
and T4 for the new AEC dose settings All images were BI-RADS category 2 and the template was inserted in an area of  glandularity value equal to
11%.
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F. 6. AFROC curves for all readers for (a) all lesions (b) microcalcification clusters (c) masses. Results are for part 1 of the study for all thickness groups.
The same analysis performed for all lesions was repeated
for microcalcification clusters and masses separately. The
results found for microcalcifications, Fig. 6(b) and Table III,
show a trend similar to the results for all lesions. The AFROC
area falls from 0.749 to 0.506 as breast thickness increases.
In Table IV, no significant differences were found for the
paired comparison of T1–T2 and T3–T4. All of the other
pairs of thickness groups were significantly different from
each other. The analysis of the masses showed a different trend
[Fig. 6(c) and Table III]. The T1 AFROC area is larger than
the areas for the other T-groups - these remaining T-groups
have a similar AFROC area, 0.609, 0.561 and 0.623 for T2, T3
and T4 respectively. The p-values listed in Table IV confirm
these results showing p-values smaller than 0.05 when T1
is compared to all other groups while there is no significant
difference for the other paired groups.
3.D. Part 2—Lesion detectability as a function
of different AEC dose settings
3.D.1. Analysis for all lesions
Results for part 2 of the study, considering all lesions, are
shown in Figs. 7(a) and 8(a) for T3 and T4 respectively. In
these graphs, the AFROC curves are compared with the results
obtained with the standard AEC setting (Fig. 6); FoM values
of the curves are listed in Table V. The AFROC areas for
both T3 and T4 are larger compared to the standard AEC
setting used in part 1 and in particular they are both equal
to 0.652. The results of the comparison of the paired groups
for the different AEC settings, i.e., the comparison of part
1 to part 2, is shown in Table VI which shows a significant
difference between the two settings for the thickness group
T3 (p-value = 0.0004, 95% CI = 0.0443, 0.1531). There is
no significant difference for the group T4 (p-values = 0.1305,
95% CI =−0.0337, 0.2076).
3.D.2. Analysis for microcalcification clusters
and masses treated separately
The results for the separate analyses of microcalcification
clusters and masses are similar to considering all lesions
together. The AFROC areas increased for the new AEC
setting when compared to the (lower dose) standard AEC.
The results are shown in Figs. 7 and 8 and the values are
listed in Table V. Considering only the microcalcification
clusters, the paired settings for both groups T3 and T4 showed
a significant difference between these groups. There is no
significant difference for the analysis of the masses. The
p-value for the T3 groups is equal to 0.0644 and for T4
0.5525.
3.E. Combined AEC settings
To conclude the study, an analysis of combined AEC
settings was performed. This analysis evaluated the influence
of thicknesses on detectability combining the results obtained
in part 1 and 2. In particular the results of thickness groups
T1 and T2 of part 1 (standard AEC dose settings) and the
results of thickness groups T3 and T4 of part 2 (new AEC
dose settings) were combined. The aim of this last analysis
is to verify whether, by combining the settings, detectability
of lesions can be considered constant for breast thicknesses
above 30 mm. Results of the FoM, plotted as LLF as a
function of FPF, are shown in Fig. 9 for (a) all lesions, (b)
T III. Figure of merit for the  analysis (AFROC area) shown for the different thickness groups and
investigated for the first part of the study. Results are presented for all lesions and for microcalcification clusters
and masses separately.
FoM (AFROC area)—Study part 1 (standard AEC setting)
Breast thickness groups compared All lesions Microcalcification clusters Masses
T1 (≤29 mm) 0.802 0.749 0.855
T2 (30–49 mm) 0.650 0.691 0.609
T3 (50–69 mm) 0.553 0.545 0.561
T4 (≥70 mm) 0.565 0.506 0.623
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T IV. The p-values and 95% confidence interval for the comparison of the different breast thickness groups
investigated in part 1 of the study. A p-value smaller than 0.05 and a CI that does not include zero mean
a significant difference between the two investigated thickness groups. The symbol · indicates no significant
difference between the paired groups. Results are listed for all lesions and for microcalcification clusters and
masses separately.
Study part 1 (standard AEC dose setting)
All lesions Microcalcification clusters MassesBreast thickness
groups compared p-value 95% CI p-value 95% CI p-value 95% CI
T1–T2 0.0003 0.0722, 0.2311 0.2322· −0.0377,0.1519 0.0000 0.1360, 0.3565
T1–T3 0.0000 0.1694, 0.3284 0.0001 0.1085, 0.2982 0.0000 0.1842, 0.4047
T1–T4 0.0000 0.1580, 0.3169 0.0000 0.1480, 0.3376 0.0000 0.1218, 0.3423
T2–T3 0.0169 0.0177, 0.1767 0.0032 0.0514, 0.2411 0.3905· −0.0621,0.1585
T2–T4 0.0346 0.0063, 0.1652 0.0003 0.0909, 0.2806 0.7999· −0.1245,0.0960
T3–T4 0.7757· −0.0909, 0.0680· 0.4064· −0.0553, 0.1344· 0.2663· −0.1727, 0.0478·
microcalcification clusters, and (c) masses. The values of the
AFROC areas were previously listed in Tables III and V. For
the analysis of all lesions in Fig. 9(a), it can be seen that
there is almost no difference for the curves of the thickness
groups T2, T3, and T4 with areas of 0.650, 0.652, and 0.652,
respectively, while T1 has a larger area equal to 0.802. These
results are confirmed by the p-values and 95% CI data listed
in Table VII. Significant differences were obtained when the
group T1 is compared to all the other groups, while there
is no significant difference for all the other paired groups.
The same trend was found for the analysis of the masses,
Fig. 9(c) and Table VII. A slightly different trend is seen for
the microcalcification clusters where the AFROC areas are
equal to 0.749, 0.691, 0.665, and 0.643 going from T1 to
T4. The p-values, Table VII, showed no significant difference
between all paired groups, except for the comparison of T1
and T4 which has a p-value of 0.0408 and a 95% CI of (0.0863,
0.3042).
4. DISCUSSION
In the first part of this study the effect of compressed
breast thickness on lesion detection was investigated using
simulated lesions inserted in real mammograms acquired
under the current standard clinical AEC settings. This is
an AEC setup that produces a constant pixel value when
tested with different thicknesses of homogenous PMMA
plates, used as a surrogate for breast thickness. Using a test
object as simple as a 2 mm thick Al sheet of 1×1 cm on
a homogenous background as well as more sophisticated
d ′ measures or contrast detail analyses show a reduction
in performance with increasing PMMA thickness.16 Results
from the more detailed clinical simulation study reported here,
showed a similar, significant decrease in lesion detection when
compressed breast thickness increases. A similar decreasing
trend was seen when the analysis was performed only for the
microcalcification clusters while for the detection of masses
this trend was less clear. The detection of masses for this AEC
setting was not significantly different for compressed breast
thicknesses above 30 mm [see Fig. 6(c)]. This reduction in
detectability can be partly explained by the increasing quantity
of scattered radiation, together with a reduction in primary
contrast as breast thickness increases.38,39 A number of studies
have shown that the detection of objects smaller than 1 mm is
mainly quantum noise limited while the detection of larger
detail structures is mainly limited by breast parenchymal
patterns.40,41 This study uses real clinical images, with both
quantum and anatomical structured noise levels set by the
acquired mammography images. The absence of a drop in
detectability of the masses in the highest thickness group
may be due to features in the anatomical background for this
F. 7. AFROC curves for all readers for thickness group T3 (50–69 mm). (a) All lesions, (b) microcalcification clusters, and (c) masses. Comparison of the
two different AEC dose settings (part 1: standard AEC dose, part 2: new AEC dose settings).
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F. 8. Alternative free-response receiver operating characteristic curves (AFROC) for all readers for thickness group T4 (>70 mm). (a) All lesions, (b)
microcalcification clusters, and (c) masses. Comparison of the two different AEC settings (part 1: standard AEC dose, part 2: new AEC dose settings).
thickness class. Although we have inserted each particular
lesion model in a breast segment of a given glandularity
measure that was fixed among the thickness groups, some
particular aspects of the background structure could not be
controlled. A typical example is the fact that the thickest
breasts tend to have small islands of glandular tissue when
compared to the more global distribution of glandular tissue in
thinner breasts that tend to isolate the potential location of the
simulated lesion and hence may influence mass detectability.
This potential bias was not considered a negative aspect of
the study as we aimed to be representative of the clinical
environment.
In the second part of the work the mammograms used for
insertion of simulated lesions were acquired with higher doses
than the standard settings. These settings were based on the
results of a previous study17 describing an AEC setup that
maintains a theoretical index of detectability constant as a
function of object thickness. The results of the present study
showed a significant increase in detection of all lesions for the
thickness group T3 but not for T4. A significant increase was
found in microcalcification cluster detection for both thickness
groups (T3 and T4) while for masses the increase was not
significant. Even if there is a lack of statistical significance,
it is important to note that for the group T3 the detection rate
of subtle masses has increased from 33% to 44%. Contrary
to the result for microcalcifications, the number of detected
masses decreased slightly between parts 1 and 2 for thickness
group T4, resulting in a nonsignificant p-value (p= 0.5525)
for the AFROC FoM. The AFROC curve itself for part 2
(T4) lies above that of part 1 (T4) for masses [Fig. 8(c)]
and this is a result of different FP rates for these datasets.
The number of nonvisible and obvious cases scored was
not different between part 1 and part 2. A relevant further
T V. Figure of merit for the  analysis (AFROC area) shown for the
different thickness groups for both parts of the study with microcalcification
clusters and masses considered together and separately.
FoM (AFROC area)—Study part 2 (new AEC dose settings)
All lesions Microcalcification clusters Masses
T3 (50–69 mm) 0.652 0.665 0.638
T4 (≥70 mm) 0.652 0.643 0.660
investigation could be the quantification of the number of
subtle and obvious lesions detected in screening programs.
These data would allow us to calculate the impact our study
would have on a screening population. These results for
microcalcifications and masses were previously seen in the
work of Samei et al. and Ruschin et al.14,15 These studies both
investigated the detectability of microcalcification and masses
at reduced dose levels by adding noise to images, and found
a significant decrease in microcalcification detectability but
no significant difference in mass detectability as a function
of dose. In both studies, the authors suggested that any dose
reduction should be applied with caution. For ethical reasons,
most previous studies on mammography operating points have
investigated the effects of dose reduction by simulating an
increase in image noise. In fact, the study described here
has taken the opposite approach, to increase the dose while
remaining within both the current Achievable and Acceptable
dose levels in the European Guidelines.20 It is less clear cut
that an increase in dose may lead to an increase in object
detectability as structure noise may start to dominate object
detection at higher doses. Figure 6(b) shows that structure
noise is already dominating detection of masses even for the
standard AEC setting.
This study has also shown that combining the standard
mammographic settings for compressed breast thicknesses up
to 49 mm with the increased doses settings for compressed
breast thicknesses above 50 mm resulted in equal detectability
for all lesions and masses for thicknesses above 30 mm.
For microcalcification clusters, no significant difference
between all T-groups, apart from the T1–T4 comparison
was found. As a general conclusion, these data suggest that
(technical) detectability performance can be set using test
object methods as a function of simulated breast thickness
and this performance follows through to clinically realistic
detection results. In this work the detectability level was
set at the level of the 30–49 mm group for all thick
breasts. This compensated for the fall in detectability seen
in constant PV AEC regimes: the situation of a decrease
in detectability as a function of thickness was changed into
an equal/constant detectability. This result was predicted in
earlier studies17,42 and therefore this study has confirmed
the possibility of reaching constant lesion detectability in
clinical images by reprogramming the AEC device, such
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T VI. The table shows the p-values and the 95% confidence interval for the comparison of the different AEC
settings investigated in part 2 of the study for the breast thickness groups T3 and T4. A p-value smaller than 0.05
and a CI that does not include zero means a significant difference between the two AEC settings investigated for
a specific breast thickness group. The symbol · indicates no significant difference. Results are listed for all lesions
and for microcalcification clusters and masses separately.
Study part 2 (new AEC dose settings)
All lesions Microcalcification clusters MassesAEC settings
compared p-value 95% CI p-value 95% CI p-value 95% CI
T3–T3 0.0004 0.0443, 0.1531 0.0074 0.0364, 0.2037 0.0644· −0.0047,0.1595
T4–T4 0.1305· −0.0337,0.2076 0.0322 0.0148, 0.2594 0.5525· −0.0947,0.1683
that a specific theoretical detectability index is kept constant.
Moreover it has shown that conclusions derived from simple
test objects, imaged against a homogeneous background, can
make predictions of lesion detectability that apply to clinical
images, containing structured anatomical noise. This finding
has important implications for quality control and assurance
programs, implying that that the methods applied by medical
physicists can have a substantial, positive influence on clinical
image quality. The constant PV AEC scheme is not just
confined to the Siemens Inspiration systems used in this study
but is currently implemented on most other mammography
systems. We therefore expect a fall in lesion detectability with
breast thickness for other such AEC designs and the modified
AEC scheme to improve detectability for thicker breasts.
Increasing the doses in groups T3 and T4 appears to be
a straightforward means of making lesion detectability more
constant among women and significantly increasing lesion
detection rates, but these increased doses and associated
patient risk should be justified. Risk benefit calculations for
breast cancer screening were considered beyond the scope of
present work. In general, the increase of doses can be justified
if this action results in an increase of lives saved by an earlier
detection of cancer, balanced against cancers induced by the
exposure. As a first approach, we can use the data of Law
et al.43 for the calculation of the ratio of detected/induced
cancers in screen/film mammography. It can be seen that the
doses used in this study for the modified AEC (part 2) are
similar or lower to those used in screen/film mammography
described by Law et al.44 As a first step, we suggest that if
benefit compared to the risk was acceptable for screen-film
mammography, we can assume that it is also acceptable for
the newly proposed AEC setting. In our study, we showed
improved detectability for subtle lesions. Our radiologists
stressed this fact: this feature will help clinicians find the
smallest cancers that have a large impact on the efficiency of
breast screening programs. The benefit to risk balance may
therefore even be improved when compared to the standard
AEC settings, but this certainly warrant further study.
Four radiologists (two from Belgium, one from Austria
and one from the United Kingdom) were consulted about
an increase of dose for breast thicknesses above 49 mm
in order to obtain a more constant lesion detectability.
This was done to gauge the willingness of clinicians to
accept the use of increased doses for some patient groups.
They all underlined the difficulty of imaging thick breasts,
notwithstanding the general consensus regarding the easier
reading of fatty breasts. It was felt that increasing dose has
a significant effect on microcalcification cluster detection
and there is a trend of improvement on the visibility of
masses but when the difficulties related to the positioning
and compression of thicker breast are taken into account, then
the increase of dose could help to counteract some of these
difficulties, leading to an improvement in lesion detection. In
fact, for thick breasts, the combination of low doses along
with nonoptimal breast compression breast could lead to
even worse situations than those examined in part 1 of the
study. Based on our results, radiologists concluded that the
increase in dose is perhaps not needed for the visualization
of small invasive carcinoma, provided all other aspects of
image acquisition (i.e., compression and positioning of the
F. 9. Alternative free-response receiver operating characteristic curves (AFROC) for all readers for (a) all lesions, (b) microcalcification clusters, and (c)
masses. Results are for parts 1 and 2 of the study combined for all thickness groups.
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T VII. The table shows the p-values and the 95% confidence interval for the comparison of thickness groups
T1 and T2 of part 1 and T3 and T4 of part 2. A p-value smaller than 0.05 and a CI that does not include zero
means a significant difference between the two AEC settings investigated for a specific breast thickness group.
The symbol · indicates no significant difference. Results are listed for all lesions and for microcalcification clusters
and masses separately.
Combined AEC settings
All lesions Microcalcification clusters MassesBreast thickness groups
compared p-value 95% CI p-value 95% CI p-value 95% CI
T1–T2 0.0005 0.0692, 0.2342 0.2602· −0.0440, 0.1582· 0.0000 0.1373, 0.3552
T1–T3 0.0006 0.0677, 0.2327 0.1036· −0.0178,0.1844· 0.0001 0.1081, 0.3560
T1–T4 0.0006 0.0680, 0.2330 0.0408 0.0046, 0.2068 0.0005 0.0863, 0.3042
T2–T3 0.9713· −0.0840,0.0810· 0.6031· −0.0749,0.1273· 0.5982· −0.1380,0.0798
T2–T4 0.9771· −0.0837,0.0813· 0.3364· −0.0524,0.1497· 0.3570· −0.1599,0.0579
T3–T4 0.9943· −0.0822,0.0828· 0.6558· −0.0786,0.1235· 0.6930· −0.1308,0.0871·
breast) are optimized. On the other hand, the significant
decrease of visibility for the microcalcification clusters using
the standard AEC settings will mean that the first signs
of malignancy go largely undetected in larger breasts. The
radiologists interviewed in the frame of the present study
indicated a definite preference for the new AEC settings.
The solution to improving sensitivity and specificity of lesion
detection in screening programs will be a combination of
factors, including the use of optimized AEC regimes together
with the use of advanced 3D breast imaging techniques such
as breast tomosynthesis, for lesions of which detection is
currently limited by breast anatomical structure.
5. CONCLUSIONS
This work has investigated lesion detectability as a
function of compressed breast thickness via the simulation
of masses and microcalcification clusters into real mammo-
grams. Detectability for simulated lesions was found to
decrease as compressed breast thickness increased, as pre-
dicted by technical Quality Control measurements. A modified
AEC setup was implemented for breast thicknesses above
50 mm, in which dose to the detector was varied in response to
increasing breast thickness in order to maintain technical (QC)
measures of detectability constant. The modified AEC scheme
increased detectability significantly for microcalcifications
simulated into the two largest thickness groups, bringing
detectability in breasts of thickness 30 mm and above up to a
constant level. For the group T4 (breast thickness ≥70 mm),
the dose increase did not yield an improvement in mass
lesion detectability, suggesting that alternative methods such
as breast tomosynthesis are needed to overcome anatomical
structure noise and improve mass detection. These results
reinforce the utility of technical measurements made as part of
routine QC performance assessments and that such data are in
fact related to the detection of simulated lesions in real clinical
backgrounds. Implementation of the modified AEC scheme
should help to move 2D mammography imaging towards
constant lesion detectability, irrespective of compressed breast
thickness.
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